Clinical Trial Update: Infusion of Depleted T Cells Following Unrelated Donor Stem Cell Transplant (ICAT) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial assessing infusion of depleted T cells after unrelated donor stem cell transplant for hematological malignancies has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematological Malignancies

Snippet

Sponsor: University College, London | Conditions: Haematological Malignancies | Phase 1, Phase 2 | Status: COMPLETED